These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 25549146)

  • 21. Statistical analysis of the concordance of immunohistochemical stains with the final diagnosis in spitzoid neoplasms.
    Puri PK; Ferringer TC; Tyler WB; Wilson ML; Kirchner HL; Elston DM
    Am J Dermatopathol; 2011 Feb; 33(1):72-7. PubMed ID: 20700039
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Application of immunohistochemistry in breast pathology: a review and update.
    Liu H
    Arch Pathol Lab Med; 2014 Dec; 138(12):1629-42. PubMed ID: 25427042
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The utility of immunohistochemistry in the differential diagnosis of gynecologic disorders.
    Kaspar HG; Crum CP
    Arch Pathol Lab Med; 2015 Jan; 139(1):39-54. PubMed ID: 25549143
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The application of immunohistochemical biomarkers in urologic surgical pathology.
    Wilkerson ML; Lin F; Liu H; Cheng L
    Arch Pathol Lab Med; 2014 Dec; 138(12):1643-65. PubMed ID: 25427043
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Merkel cell carcinoma exhibiting cytoplasmic OCT4 staining: a potential new diagnostic immunohistochemical marker.
    Kao CS; Warren S; Idrees MT
    Am J Dermatopathol; 2014 Mar; 36(3):274-6. PubMed ID: 23863554
    [No Abstract]   [Full Text] [Related]  

  • 26. Tissue microarrays are an effective quality assurance tool for diagnostic immunohistochemistry.
    Hsu FD; Nielsen TO; Alkushi A; Dupuis B; Huntsman D; Liu CL; van de Rijn M; Gilks CB
    Mod Pathol; 2002 Dec; 15(12):1374-80. PubMed ID: 12481020
    [TBL] [Abstract][Full Text] [Related]  

  • 27. p16 loves me, p16 loves me not.
    McCalmont TH
    J Cutan Pathol; 2012 Dec; 39(12):1060-1. PubMed ID: 23181443
    [No Abstract]   [Full Text] [Related]  

  • 28. Anti-cytokeratin CAM 5.2 does not act as a surrogate of the cytokeratin 8/18 monoclonal antibody. Comment on: "Utility of p63 in the differential diagnosis of atypical fibroxanthoma and spindle cell squamous cell carcinoma", in J Cutan Pathol 2009; 36: 543.
    Chen JT; Hsu JD; Yao CC; Han LW; Han CP
    J Cutan Pathol; 2010 Oct; 37(10):1123-4. PubMed ID: 20175827
    [No Abstract]   [Full Text] [Related]  

  • 29. CK7+/CK20- Merkel cell carcinoma presenting as inguinal subcutaneous nodules with subsequent epidermotropic metastasis.
    Tsai YY; Hsiao CH; Chiu HC; Chen M; Tsai TF
    Acta Derm Venereol; 2010 Jul; 90(4):438-9. PubMed ID: 20574624
    [No Abstract]   [Full Text] [Related]  

  • 30. Immunohistochemistry in dermatopathology: a review of the most commonly used antibodies (part I).
    Fuertes L; Santonja C; Kutzner H; Requena L
    Actas Dermosifiliogr; 2013 Mar; 104(2):99-127. PubMed ID: 23062957
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunohistochemistry is highly sensitive and specific for the detection of V600E BRAF mutation in melanoma.
    Long GV; Wilmott JS; Capper D; Preusser M; Zhang YE; Thompson JF; Kefford RF; von Deimling A; Scolyer RA
    Am J Surg Pathol; 2013 Jan; 37(1):61-5. PubMed ID: 23026937
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High sensitivity and reproducibility of immunohistochemistry with microagitation.
    Nindl I; Toegl A; Sterry W; Stockfleth E
    Arch Dermatol Res; 2004 Nov; 296(6):278-81. PubMed ID: 15517323
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MCM 2 Expression in Basal Cell Carcinomas and Trichoepitheliomas.
    Liaw K; Boyd AS
    J Cutan Pathol; 2009 Oct; 36(10):1121-2. PubMed ID: 19522849
    [No Abstract]   [Full Text] [Related]  

  • 34. Application of immunohistochemistry in the differential diagnosis of skin tumors.
    Googe PB; Bhan AK; Mihm MC
    Clin Lab Med; 1990 Mar; 10(1):179-97. PubMed ID: 2184977
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Applications of electron microscopy in dermatology].
    Sterniczky B; Födinger D; Sauter B; Rappersberger K
    Hautarzt; 1996 Feb; 47(2):148-65 quiz 162-3. PubMed ID: 8868462
    [No Abstract]   [Full Text] [Related]  

  • 36. Diagnostic value of Sox10 immunohistochemical staining for the detection of metastatic melanoma in sentinel lymph nodes.
    Blochin E; Nonaka D
    Histopathology; 2009 Nov; 55(5):626-8. PubMed ID: 19912373
    [No Abstract]   [Full Text] [Related]  

  • 37. Immunohistochemistry and molecular diagnostics of pleural malignant mesothelioma.
    Betta PG; Magnani C; Bensi T; Trincheri NF; Orecchia S
    Arch Pathol Lab Med; 2012 Mar; 136(3):253-61. PubMed ID: 22372901
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Microphthalmia transcription factor immunohistochemistry: a useful diagnostic marker in the diagnosis and detection of cutaneous melanoma, sentinel lymph node metastases, and extracutaneous melanocytic neoplasms.
    O'Reilly FM; Brat DJ; McAlpine BE; Grossniklaus HE; Folpe AL; Arbiser JL
    J Am Acad Dermatol; 2001 Sep; 45(3):414-9. PubMed ID: 11511840
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lymphatic invasion detected by D2-40/S-100 dual immunohistochemistry does not predict sentinel lymph node status in melanoma.
    Petitt M; Allison A; Shimoni T; Uchida T; Raimer S; Kelly B
    J Am Acad Dermatol; 2009 Nov; 61(5):819-28. PubMed ID: 19836642
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cutaneous involvement by CD5-negative chronic lymphocytic leukemia (CLL)--aberrant phenotype or false negativity? Implications for immunohistochemical testing on paraffin-embedded skin specimens.
    Murphy M; Hoss D
    J Cutan Pathol; 2011 Jan; 38(1):73-5. PubMed ID: 20880388
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.